These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12076394)

  • 41. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.
    Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M
    Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study.
    Benetti G; Borzio M; Ramella G; Bellati G; Fargion S; Colombo A; Croce G; Iamoletti C; Balzola F; Rizzetto M;
    Intern Emerg Med; 2006; 1(2):113-8. PubMed ID: 17111783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
    Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
    Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
    Bizollon T; Ahmed SN; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
    Gut; 2003 Feb; 52(2):283-7. PubMed ID: 12524414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of the treatment of chronic hepatitis C virus infection in cirrhosis.
    Vezali E; Aghemo A; Colombo M
    Clin Ther; 2010 Dec; 32(13):2117-38. PubMed ID: 21316532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.
    Simin M; Brok J; Stimac D; Gluud C; Gluud LL
    Aliment Pharmacol Ther; 2007 May; 25(10):1153-62. PubMed ID: 17451561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.
    Mangia A; Minerva N; Annese M; Leandro G; Villani MR; Santoro R; Carretta V; Bacca D; Giangaspero A; Bisceglia M; Ventrella F; Dell'Erba G; Andriulli A
    Hepatology; 2001 Apr; 33(4):989-93. PubMed ID: 11283865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
    Desai TK; Jamil LH; Balasubramaniam M; Koff R; Bonkovsky HL
    Dig Dis Sci; 2008 Mar; 53(3):815-22. PubMed ID: 17846887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of naive patients with chronic hepatitis C.
    Weiland O
    J Hepatol; 1999; 31 Suppl 1():168-73. PubMed ID: 10622581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation.
    Gurusamy KS; Tsochatzis E; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006573. PubMed ID: 21154370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.
    Helbling B; Stamenic I; Viani F; Gonvers JJ; Dufour JF; Reichen J; Cathomas G; Steuerwald M; Borovicka J; Sagmeister M; Renner EL;
    Hepatology; 2002 Feb; 35(2):447-54. PubMed ID: 11826422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
    Chou R; Carson S; Chan BK
    J Viral Hepat; 2008 Aug; 15(8):551-70. PubMed ID: 18482285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.
    Melian EB; Plosker GL
    Drugs; 2001; 61(11):1661-91. PubMed ID: 11577799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
    Saracco G; Ciancio A; Ghisetti V; Rocca G; Cariti G; Andreoni M; Tabone M; Roffi L; Calleri G; Ballaré M; Terreni N; Sartori M; Tappero GF; Traverso A; Poggio A; Orani A; Maggi G; Di Napoli A; Arrigoni A; Rizzetto M;
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):149-55. PubMed ID: 11246614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
    Chung RT; Andersen J; Volberding P; Robbins GK; Liu T; Sherman KE; Peters MG; Koziel MJ; Bhan AK; Alston B; Colquhoun D; Nevin T; Harb G; van der Horst C;
    N Engl J Med; 2004 Jul; 351(5):451-9. PubMed ID: 15282352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
    Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
    Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.